#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA631987	A	Oral bioavailability in human	Homo sapiens	3	ALA1133765	organism-based format	Scientific Literature
2.	ALA634283	P	Partition coefficient (logD6.5)		114	ALA1133765	small-molecule physicochemical format	Scientific Literature
3.	ALA637372	A	Delta logD (logD6.5 - logD7.4)		1	ALA1133765	assay format	Scientific Literature
4.	ALA874960	P	Ionization constant (pKa)		42	ALA1133765	small-molecule physicochemical format	Scientific Literature
5.	ALA700847	F	Percentage growth inhibition of Toxoplasma gondii at concentration of 2 ug/mL using an human myelomonocytic cell line THP-1	Homo sapiens	15	ALA1133348	cell-based format	Scientific Literature
6.	ALA715807	F	Effective dose was determined in vivo for 50% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration	Mus musculus	4	ALA1133699	organism-based format	Scientific Literature
7.	ALA715808	F	Effective dose was determined in vivo for 50% parasite (Plasmodium berghei) reduction in the male albino mice after subcutaneous administration	Mus musculus	4	ALA1133699	organism-based format	Scientific Literature
8.	ALA715810	F	Effective dose was determined in vivo for 90% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration	Mus musculus	4	ALA1133699	organism-based format	Scientific Literature
9.	ALA877240	F	Effective dose was determined in vivo for 90% parasite (Plasmodium berghei) reduction in the male albino mice after subcutaneous administration	Mus musculus	2	ALA1133699	organism-based format	Scientific Literature
10.	ALA764700	F	In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum K1	Plasmodium falciparum	29	ALA1133699	organism-based format	Scientific Literature
11.	ALA762993	F	In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54	Plasmodium falciparum	29	ALA1133699	organism-based format	Scientific Literature
12.	ALA761721	F	Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes	Plasmodium falciparum	27	ALA1134176	organism-based format	Scientific Literature
13.	ALA835732	F	Inhibitory concentration against the growth of Toxoplasma gondii overexpressing FPPS enzyme in human foreskin fibroblast monolayer cells; (control = 0.29 uM)	Homo sapiens	1	ALA1143625	cell-based format	Scientific Literature
14.	ALA910392	F	Growth inhibition of Plasmodium falciparum ring stage in infected erythrocytes by DAPI growth assay	Plasmodium falciparum	4	ALA1142194	organism-based format	Scientific Literature
15.	ALA910393	F	Growth inhibition of Plasmodium falciparum ring stage in infected erythrocytes by DAPI growth assay	Plasmodium falciparum	4	ALA1142194	organism-based format	Scientific Literature
16.	ALA910394	F	Growth inhibition of Plasmodium falciparum as reduced [3H]hypoxanthine incorporation	Plasmodium falciparum	4	ALA1142194	organism-based format	Scientific Literature
17.	ALA918322	F	Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 gametocytes (stage 2 & 3)	Plasmodium falciparum	6	ALA1147097	organism-based format	Scientific Literature
18.	ALA918323	F	Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 gametocytes (stage 4 & 5)	Plasmodium falciparum	6	ALA1147097	organism-based format	Scientific Literature
19.	ALA918324	F	Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 asexual gametocytes	Plasmodium falciparum	6	ALA1147097	organism-based format	Scientific Literature
20.	ALA919805	F	Inhibition of Toxoplasma gondii RH replication in human foreskin fibroblasts incubated for 24 hrs with drug after 36 hrs postinfection by immunofluorescence microscopy	Toxoplasma gondii	2	ALA1147098	organism-based format	Scientific Literature